medullary thyroid cancer and glp-1 GLP-1RA cancer: New study suggests detection bias, not causation Glucagon-like peptide 1 receptor agonist

Your family notices you're weaker

Forbes just released their list of top-rated GLP-1 providers for 2025

Discover Personalized Pricing Tailored to Your Weight Loss Journey.

Conclusion For patients experiencing weight regain after bariatric surgery, two-thirds of the weight regain can be safely lost with GLP1-RA, providing clinicians with a therapeutic option for this clinical challenge, and highlights the need for a large-scale randomized clinical trial

To unlock their potential for clinical applications, future studies may move beyond anticipated rewards to cover other reward facets

GLP-1 agonists have gained a tremendous amount of attention over the last few years for their potential to help people lose weight. And while this may seem amazing, especially for thyroid patients who have struggled